Grail, Inc. (NASDAQ:GRAL - Get Free Report) shares were up 9.2% on Tuesday . The company traded as high as $18.65 and last traded at $19.02. Approximately 79,081 shares were traded during trading, a decline of 88% from the average daily volume of 661,364 shares. The stock had previously closed at $17.42.
Analyst Upgrades and Downgrades
A number of equities analysts recently weighed in on GRAL shares. Guggenheim started coverage on shares of Grail in a report on Thursday, October 17th. They set a "neutral" rating on the stock. Wolfe Research started coverage on shares of Grail in a report on Friday, November 15th. They set a "peer perform" rating on the stock. Finally, Morgan Stanley assumed coverage on shares of Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 target price on the stock.
Check Out Our Latest Research Report on Grail
Grail Trading Up 14.7 %
The business has a 50-day simple moving average of $18.57.
Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported ($3.94) EPS for the quarter. The business had revenue of $28.65 million for the quarter. As a group, equities analysts predict that Grail, Inc. will post -65.16 EPS for the current fiscal year.
Insider Activity
In other news, CFO Aaron Freidin sold 30,452 shares of the business's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the sale, the chief financial officer now owns 268,277 shares of the company's stock, valued at approximately $3,761,243.54. The trade was a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Institutional Investors Weigh In On Grail
A number of institutional investors have recently modified their holdings of GRAL. Douglas Lane & Associates LLC bought a new stake in shares of Grail in the fourth quarter valued at about $3,034,000. A. D. Beadell Investment Counsel Inc. bought a new stake in Grail during the fourth quarter worth about $430,000. FNY Investment Advisers LLC bought a new stake in Grail during the fourth quarter worth about $26,000. 180 Wealth Advisors LLC bought a new stake in Grail during the fourth quarter worth about $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management bought a new stake in Grail during the fourth quarter worth about $387,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
